Clinical trial · Interventional
Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.
Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions. Aim 3: Assess the Feasibility and Acceptability of the PINPOINT Intervention.
NCT07351110CI-TRIAL-00121277PINPOINTrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Our overarching goal is to adapt and test the PINPOINT intervention -PatIent Navigation for the Prevention of CervIcal CaNcer inTervention. We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer (Early Detection) | Malignant Cervical Neoplasm | CURATED_EXACT | 0.85 |
| Diabetes | — | UNRESOLVED | — |
| Obesity & Overweight | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| patient navigation and self-collection | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- PINPOINT intervention arm will entail assigning patients to a patient navigator to assist them with screening reminders and address any barriers they have to screening, education on cervical cancer screening, and patients will also be offered the opportunity to self-collect their sample for cervical cancer screening.
- interventionNames
- Behavioral: patient navigation and self-collection
- type
- NO_INTERVENTION
- label
- Control Arm
- description
- No intervention arm, patients will receive reminders for screening according to current clinical practice
Primary outcomes (1)
- measure
- Cervical cancer screening
- timeFrame
- within 6 months
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: The following eligibility criteria will be used to determine inclusion into the study: 1. Using the American Cancer Society (ACS) screening recommendations, adults aged over the age of 25 will be eligible 2. Active UF Internal Medicine patient and has had an appointment in the last 2 months. 3. Assigned sex at birth is female 4. Have Obesity or Type 2 Diabetes 5. Not currently pregnant (self-report) 6. Have not given birth in the prior 12 weeks 7. No previous history of cervical cancer 8. No previous history of a hysterectomy 9. Have not undergone cancer screening in the past 3 years or more 10. Reside in the UFHCI Catchment Area (Alachua, Baker, Bradford, Citrus, Clay, Columbia, Dixie, Gadsden, Gilchrist, Hamilton, Jefferson, Lafayette, Lake, Leon, Levy, Madison, Marion, Putnam, Sumter, Suwannee, Taylor, UnioF1n, or Wakulla County). 11. Have a mobile phone or access to a mobile phone that can be used to receive messages, or a valid email address. 12. Are not currently scheduled to receive cervical cancer screening via clinician sampling (pap smear). Exclusion Criteria: * Previous history of cervical cancer * Total hysterectomy * Pregnant
References
Publications (3)
- BACKGROUNDMkuu RS, Staras SA, Szurek SM, D'Ingeo D, Gerend MA, Goede DL, Shenkman EA. Clinicians' perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study. BMC Cancer. 2022 Mar 9;22(1):252. doi: 10.1186/s12885-022-09350-5. PMID 35264120
- BACKGROUNDMkuu RS, Tohme S, Rivero-Mendoza D, Salloum RG, Goede D, Bruggeman B, Nicholson K, Hall JM, Bylund C, Woodard JN, Hensley J, Shenkman EA, Donahoo WT, Mulugeta A, Hernandez M, Staras SA. Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer. Cancer Manag Res. 2025 Dec 24;17:3273-3284. doi: 10.2147/CMAR.S552282. eCollection 2025. PMID 41467104
- BACKGROUNDMkuu RS, Staras SA, Chakrabarti C, Hall J, Harvey I, Salloum RG, Barrow S, Ortega S, Woodard J, Seals K, Rawls A, Meduri Y, Donahoo WT, Goede DL, Shenkman EA. Acceptability of HPV self-collection: A qualitative study of Black women living with type II diabetes and social vulnerability. J Clin Transl Endocrinol. 2024 Feb 25;35:100331. doi: 10.1016/j.jcte.2024.100331. eCollection 2024 Mar. PMID 38444842